GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InflaRx NV (NAS:IFRX) » Definitions » Pre-Tax Income

InflaRx NV (InflaRx NV) Pre-Tax Income : $-46.08 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is InflaRx NV Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. InflaRx NV's pretax income for the three months ended in Dec. 2023 was $-17.37 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-46.08 Mil. InflaRx NV's pretax margin was -868,600.00%.

During the past 9 years, InflaRx NV's highest Pretax Margin was -67434.78%. The lowest was -68771.64%. And the median was -67434.78%.


InflaRx NV Pre-Tax Income Historical Data

The historical data trend for InflaRx NV's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InflaRx NV Pre-Tax Income Chart

InflaRx NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only -59.17 -41.34 -51.56 -31.23 -46.53

InflaRx NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.50 -11.87 -8.89 -7.95 -17.37

Competitive Comparison of InflaRx NV's Pre-Tax Income

For the Biotechnology subindustry, InflaRx NV's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InflaRx NV's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Pre-Tax Income falls into.



InflaRx NV Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

InflaRx NV's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-48.973+-2.009+-0.039+4.149+0.342
=-46.53

InflaRx NV's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-14.51+-4.106+-0.022+1.169+0.096999999999998
=-17.37

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InflaRx NV  (NAS:IFRX) Pre-Tax Income Explanation

InflaRx NV's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-17.372/0.002
=-868,600.00%

During the past 9 years, InflaRx NV's highest Pretax Margin was -67434.78%. The lowest was -68771.64%. And the median was -67434.78%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InflaRx NV Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of InflaRx NV's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


InflaRx NV (InflaRx NV) Business Description

Traded in Other Exchanges
Address
Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.